These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34559885)

  • 61. The importance of functional validation after next-generation sequencing: evaluation of a novel CARD11 variant.
    Lu HY; Sharma M; Biggs CM; Huang YH; Shopsowitz KE; Frosk P; Priatel JJ; Rubin TS; Turvey SE
    Pediatr Allergy Immunol; 2018 Sep; 29(6):663-668. PubMed ID: 29808493
    [No Abstract]   [Full Text] [Related]  

  • 62. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
    Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.
    Thome M
    Nat Rev Immunol; 2004 May; 4(5):348-59. PubMed ID: 15122200
    [No Abstract]   [Full Text] [Related]  

  • 64. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
    Qiao Q; Yang C; Zheng C; Fontán L; David L; Yu X; Bracken C; Rosen M; Melnick A; Egelman EH; Wu H
    Mol Cell; 2013 Sep; 51(6):766-79. PubMed ID: 24074955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
    Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
    EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
    Schimmack G; Eitelhuber AC; Vincendeau M; Demski K; Shinohara H; Kurosaki T; Krappmann D
    Cell Commun Signal; 2014 Jul; 12():49. PubMed ID: 25245034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain.
    Lamason RL; McCully RR; Lew SM; Pomerantz JL
    Biochemistry; 2010 Sep; 49(38):8240-50. PubMed ID: 20799731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
    Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
    EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.
    Arjunaraja S; Angelus P; Su HC; Snow AL
    Front Immunol; 2018; 9():198. PubMed ID: 29472930
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
    Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
    Front Immunol; 2019; 10():297. PubMed ID: 30941118
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.
    Thome M; Charton JE; Pelzer C; Hailfinger S
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a003004. PubMed ID: 20685844
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of CARMA1/CARD11 and Bob1 as candidate genes in common variable immunodeficiency.
    Tampella G; Baronio M; Vitali M; Soresina A; Badolato R; Giliani S; Plebani A; Lougaris V
    J Investig Allergol Clin Immunol; 2011; 21(5):348-53. PubMed ID: 21905497
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency.
    Monajemi M; Fisk S; Pang YCF; Leung J; Menzies SC; Ben-Othman R; Cai B; Kollmann TR; Rozmus J; Sly LM
    J Leukoc Biol; 2019 Oct; 106(4):863-877. PubMed ID: 31313375
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
    Fontán L; Melnick A
    Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Defining the combinatorial space of PKC::CARD-CC signal transduction nodes.
    Staal J; Driege Y; Haegman M; Kreike M; Iliaki S; Vanneste D; Lork M; Afonina IS; Braun H; Beyaert R
    FEBS J; 2021 Mar; 288(5):1630-1647. PubMed ID: 32790937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation.
    Lee P; Zhu Z; Hachmann J; Nojima T; Kitamura D; Salvesen G; Rickert RC
    J Immunol; 2017 Feb; 198(3):1066-1080. PubMed ID: 28031341
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging.
    Demeyer A; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Muyllaert D; Staal J; Beyaert R
    Front Immunol; 2019; 10():2330. PubMed ID: 31632405
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A familial case of B-cell expansion with NF-κB and T-cell anergy caused by a G123D heterozygous missense mutation in the CARD11 gene.
    Takase Y; Tanioka S; Ishimura M; Yoshiura KI; Mori Y; Sakaida E; Funakoshi Y; Moriuchi H
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29941. PubMed ID: 36129242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.
    Oikawa D; Hatanaka N; Suzuki T; Tokunaga F
    Front Immunol; 2020; 11():601926. PubMed ID: 33329596
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
    Torres JM; Martinez-Barricarte R; García-Gómez S; Mazariegos MS; Itan Y; Boisson B; Rholvarez R; Jiménez-Reinoso A; del Pino L; Rodríguez-Pena R; Ferreira A; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Díaz-Almirón M; López-Collazo E; Unzueta-Roch JL; Sánchez-Ramón S; Regueiro JR; López-Granados E; Casanova JL; Pérez de Diego R
    J Clin Invest; 2014 Dec; 124(12):5239-48. PubMed ID: 25365219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.